Cell death pathway induced by resveratrol-bovine serum albumin nanoparticles in a human ovarian cell line

LIYUAN GUO,YAN PENG,YULIAN LI,JINGPING YAO,GUANGMEI ZHANG,JIE CHEN,JING WANG,LIHUA SUI
DOI: https://doi.org/10.3892/ol.2015.2851
2015-01-07
Oncology Letters
Abstract:Resveratrol-bovine serum albumin nanoparticles (RES-BSANP) exhibit chemotherapeutic properties, which trigger apoptosis. The aim of the present study was to investigate the caspase-independent cell death pathway induced by RES-BSANP in human ovarian cancer SKOV3 cells and to analyze its mechanism. Morphological changes were observed by apoptotic body/cell nucleus DNA staining using inverted and fluorescence microscopy. The cell death pathway was determined by phosphatidylserine translocation. Western blot analysis was conducted to detect the activation of apoptosis-inducing factor (AIF), cytochrome <i>c</i> (Cyto <i>c</i>) and B-cell lymphoma 2-associated X protein (Bax). Apoptotic body and nuclear condensation and fragmentation were observed simultaneously following treatment with RES-BSANP. RES-BSANP induced apoptosis in a dose-dependent manner in the human ovarian cancer SKOV3 cells. The translocation of AIF from the mitochondria to the cytoplasm occurred earlier than that of Cyto <i>c</i>. In addition, Bax binding to the mitochondria was required for the release of AIF and Cyto <i>c</i> from the mitochondria. The AIF apoptosis pathway may present an alternative caspase-dependent apoptosis pathway in human ovarian cell death induced by RES-BSANP. Elucidation of this pathway may be critical for the treatment of cancer using high doses of RES-BSANP.
oncology
What problem does this paper attempt to address?